Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons.

摘要

From the Diabetes Control and Complications Trial and the UK Prospective Diabetes Study, we learned that lowering HbA_(1c) reduces morbidity and mortality (11,12) and that tight glycemic control is associated with an increased rate of severe hypogly-cemic episodes. We therefore should judge the pros of CGM by its HbA_(1c)-lowering potency and its influence on severe hypoglycemia rates. Table 1 summarizes all intervention trials that have been performed with real-time CGM regarding HbA_(1c) and the incidence of severe hypoglycemia.